Funding for this research was provided by:
Horizon 2020 (830017)
Österreichische Forschungsförderungsgesellschaft (880939)
Fachhochschule Technikum Wien
Received: 21 December 2021
Accepted: 13 March 2022
First Online: 13 April 2022
: N. Munsch, S. Gruarin, J. Nateqi, T. Lutz, A. Martin and B. Knapp are current or past employees of Symptoma GmbH. J. Nateqi and T. Lutz hold shares of Symptoma. M. Binder and J. H. Aberle declare that they have no competing interests.
: This study was exempted from ethics review by the ethics commission of the city of Vienna (MA15-EK/21-037-VK_NZ). All individuals using the chatbot agreed that their data will be used in an anonymized way.